Walk down any supplement aisle and you will still see plenty of beautiful packaging, calming colors, and plant-inspired promises. But in 2026, what increasingly matters behind a botanical formula is not the poetry on the label. It is the lab record: identity testing, contaminant screening, plant-part disclosure, lot documentation, and a Certificate of Analysis that can actually stand up to scrutiny.
That shift matters for everyday wellness shoppers because better testing and traceability can help answer practical questions: Is this really the plant on the label? Which part of the plant was used? Was the batch checked for adulterants, pesticides, or hazardous residues? And can the brand show evidence for the specific lot in the bottle, not just vague supplier assurances? Inside the lab, botanical formulas are being judged less by marketing language and more by fingerprints, documentation, and traceable proof.
From supplier trust to documented proof
For years, many botanical supply chains leaned heavily on trust-based sourcing. A supplier would provide paperwork, a brand would accept it, and the product would move forward. That model is changing fast. One of the clearest 2026 signals comes from NSF, which says its supplement and ingredient certification programs verify that the Supplement Facts panel or the ingredient Certificate of Analysis accurately reflects identity and purity specifications, while also testing botanicals for pesticides, contaminants, and adulterants.
That may sound technical, but the takeaway is simple: testing is moving from “trust the supplier” to “show the evidence.” A botanical ingredient is no longer just a name on a spreadsheet. It is becoming a documented material tied to identity, purity, and lot-level results. For brands, that means stronger supplier qualification. For consumers, it means a higher chance that what is listed on the bottle is actually what was used.
AOAC has framed this shift well, saying the goal is to identify analytical methods that ensure all testing data provided in a Certificate of Analysis is “accurate and reliable,” which translates into “consumer safety and trust.” That quote captures the bigger picture. A COA is no longer just a formality. It is increasingly part of the traceability story itself.
Why traceability now reaches all the way to the label
Traceability is not only about knowing where an herb came from. It also includes describing it correctly. In a September 18, 2025 warning letter, the FDA said a resveratrol supplement label was misbranded because it failed to identify the product as a dietary supplement and failed to identify the part of the plant from which each botanical dietary ingredient was derived.
That detail is easy to overlook if you are not in regulatory work, but it is a big deal. “Plant part” is not marketing fluff. Root, leaf, bark, fruit, seed, and flower can differ in chemistry, safety profile, and expected activity. FDA’s 2025 warning letter to Time Challenger Labs reinforced this point by explicitly citing failure to declare the plant part. In other words, traceability now extends to botanical anatomy on label claims.
For practical shoppers, this matters because better labeling often reflects better internal control. When a company can clearly state the exact botanical identity and plant part used, it suggests the formula is being built with more discipline. If a label is vague, that can be a sign to slow down and ask harder questions.
Inside the lab: botanical identity is becoming a multi-method job
One reason botanical formulas are hard to verify is that herbs are complex natural materials. They vary by species, geography, harvest conditions, processing, and extraction methods. A single test rarely answers every question. That is why identity testing in 2025 and 2026 is becoming more multi-method, combining different tools rather than relying on one silver bullet.
AOAC’s 2025 Botanical Ingredient and Dietary Supplement Integrity update says its Botanical Identity Verification initiative, launched in June 2024, is incorporating examples involving HPTLC and DNA-based methods for botanical and fungal identity verification. AOAC also reported that its January 2024 Botanical Identity Verification Virtual Forum attracted over 100 attendees, which shows how much demand there is for clearer guidance on how to confirm what a botanical ingredient really is.
The practical lesson is that strong testing often uses orthogonal methods, meaning different approaches that check the material from different angles. One method may look at a chemical fingerprint. Another may look at genetic material. Others may include morphology, microscopy, or targeted marker analysis. The goal is not to make testing more complicated for the sake of it. The goal is to reduce blind spots.
HPTLC and fingerprinting are becoming central to botanical quality
If there is one lab technique that keeps showing up in modern botanical quality work, it is HPTLC, or high-performance thin-layer chromatography. USP’s official chapter <203> describes an HPTLC procedure specifically for use in USP identification tests for articles of botanical origin. In plain language, this is a fingerprinting tool that helps labs compare a botanical sample against a known reference pattern.
That matters because botanicals are rarely judged by one isolated compound alone. A real plant material often has a broader chemical signature, and fingerprinting can help reveal whether that signature fits the claimed botanical. USP’s broader playbook reinforces this standardized approach through chapters such as <561> Articles of Botanical Origin, <563> Identification of Articles of Botanical Origin, and <565> Botanical Extracts.
The conversation is getting even more relevant for blended products. A recent USP workshop presentation on polyherbal formulations stated that “HPTLC <203> and comprehensive HPTLC fingerprinting are the ticket” for quality description and control of poly-herbal formulations. That is important because many wellness products today are not single-herb capsules. They are layered formulas with multiple botanicals, and those formulas need testing strategies that reflect that complexity.
DNA testing is promising, but it is not the whole answer
DNA-based methods get a lot of attention because they sound precise and modern. And to be fair, they are advancing quickly. A 2025 review on authenticating herbal materials noted that adulteration remains prevalent and that more rapid and affordable on-site DNA testing is helping shape the field. That is encouraging, especially for early screening and raw material authentication.
Still, DNA is not a one-test-fits-all solution. Processing can damage or remove usable DNA, especially in extracts and heavily processed finished products. A DNA result also may not tell you everything you need to know about purity, strength, contaminants, or whether a blend was economically adulterated with non-declared materials. That is why DNA is increasingly being evaluated alongside other quality-control tools rather than replacing them.
There is also an important regulatory nuance. The same 2025 review noted that while DNA methods are progressing fast, USP and the European Pharmacopoeia had not yet included specific provisions for them. That suggests major quality systems still rely heavily on broader authentication frameworks, including chromatography, morphology, microscopy, and orthogonal testing. For consumers, the practical message is straightforward: be cautious of brands that oversell one flashy test as if it solves everything.
Contaminants, adulteration, and the hidden risks behind popular herbs
Identity is only half the story. A botanical can be the correct plant and still fail quality expectations because of contaminants or adulteration. That is why contaminant testing is expanding alongside identity work. AOAC’s 2025 program update noted that its ethylene oxide project published SMPR 2024.005 in September 2024, while its pyrrolizidine alkaloids standard SMPR 2023.002 had methods under review in 2025. This shows that botanical formulas are increasingly being screened for both authenticity and hazardous residues.
Adulteration remains a practical concern, especially in high-demand categories. USP’s elderberry standards forum noted evidence of adulteration in bulk extracts and also detected adulteration with black rice extract in some gummy or chewable gel products. That is a useful reminder that a colorful, convenient finished product can still hide supply-chain shortcuts.
Immune-health botanicals offer a good example of why this matters. A peer-reviewed review on U.S. botanical products marketed for immune health pointed to the testing challenges around ingredients such as elderberry, turmeric, and functional mushrooms, while referencing 21 CFR 111.70, which requires manufacturers to establish specifications for identity, purity, strength, composition, and contamination limits. In short, popular herbs often need more verification, not less.
Lot-level records are becoming the backbone of botanical traceability
When people hear the word traceability, they often think about country of origin or farm stories. Those details can be helpful, but regulatory traceability is more concrete than that. Under federal dietary supplement cGMPs, a “lot” is a batch or identified portion intended to meet specifications for identity, purity, strength, and composition. That definition is one reason traceability systems are increasingly built around lot-linked records and testing.
In practice, that means a serious botanical quality system should be able to tie a specific lot back to its specifications, testing results, and documentation history. This is where Certificates of Analysis, incoming ingredient verification, and retained records become so important. USP says its Ingredient Verification Program helps assure the quality of dietary ingredients and can support supplier qualification, and it has historically emphasized that verification marks can be used on bulk labels and on the certificate of analysis. That connects laboratory verification directly to supply-chain paperwork.
Traceability also reaches into stability and storage. AHPA’s guidance on shelf-life dating for botanical supplement ingredients and products highlights that federal requirements apply with particular emphasis on botanical ingredients. In other words, traceability is not just about what the material was at the start. It also includes how long it remains fit for use, how it was stored, and whether dating is properly supported.
What this means for complex formulas and more transparent shopping
Modern supplements are often messy from a quality-control standpoint because they combine botanicals with vitamins, minerals, amino acids, or specialty ingredients in one finished dose. USP recognized this growing challenge through General Chapter <2800> Multi-Ingredient Dietary Supplement Products, Product Quality Tests, which became official on December 1, 2024. Its scope includes finished dosage forms combining botanical ingredients with other nutrients, a sign that the industry can no longer treat blended products like simple extensions of single-herb testing.
Governance is also moving in the same direction. In July 2025, USP announced its 2025,2030 Expert Committee rosters, including a dedicated Botanical Dietary Supplements and Herbal Medicines committee. Public standards are still expanding too, including through USP’s Herbal Medicines Compendium, a freely available online resource for herbal ingredient standards. This ongoing investment matters because stronger public methods and expert oversight make it easier to compare quality claims across brands.
On the consumer-facing side, transparency tools are starting to catch up. GS1 Digital Link and similar QR-based systems are being promoted as ways to connect products to structured traceability data. Vendor-led services such as source-to-shelf tracking, digital product passports, and third-party validation are also entering botanical supply chains. These tools are not all regulatory standards, but they reflect a clear commercial direction: shoppers may increasingly expect to scan a product and see more than a pretty label.
The bigger picture is encouraging. FDA says the Botanical Safety Consortium aims to “enhance the botanical safety toolkit” and bring clarity to botanical dietary ingredient assessments, and that agreement was renewed in August 2025 for another five years. That tells us botanical oversight is becoming more science-led, not just paperwork-led. Better tools, better standards, and better documentation should make it harder for weak products to hide behind vague claims.
For readers trying to make smarter supplement choices, the most useful mindset is practical, not perfectionist. Look for brands that explain their testing clearly, identify the plant part, discuss lot-based quality control, and mention third-party or standards-based verification without making exaggerated promises. Inside the lab, botanical formulas are being reshaped by testing and traceability. And over time, that should make the wellness aisle a little easier to trust.
